Affiliation: Denver Health Medical Center
- Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetesKathy Love-Osborne
Division of Adolescent Medicine, Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA
Pediatr Diabetes 7:205-10. 2006..The aim of this study was to evaluate whether fasting laboratory values can predict impaired glucose tolerance (IGT) in adolescents who are at risk for developing type 2 diabetes mellitus (T2DM)...
- Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver diseaseKathy A Love-Osborne
Division of Adolescent Medicine, Department of Pediatrics, Denver Health and Hospitals, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80205, USA
J Adolesc Health 42:543-8. 2008..To evaluate whether the presence of metabolic syndrome (MS) in obese adolescents is associated with other comorbidities of obesity..
- An approach to obesity management in primary care: yes, we can make a differenceKathy Love-Osborne
Department of Pediatrics, Section of Adolescent Medicine, Denver Health and Hospitals, University of Colorado Denver Health Sciences Center, 501 28th Street, Denver, CO 80220, USA
Adolesc Med State Art Rev 20:91-108, ix. 2009..Medications used for the treatment of comorbidities are reviewed also...
- Addition of metformin to a lifestyle modification program in adolescents with insulin resistanceKathy Love-Osborne
Division of Adolescent Medicine, University of Colorado at Denver, Denver, Colorado, USA
J Pediatr 152:817-22. 2008..To evaluate whether metformin, when added to a program of personal goal setting, improves weight loss and clinical status in obese adolescents...
- Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescentsKristen J Nadeau
Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
Pediatr Diabetes 10:5-13. 2009..While metformin plus lifestyle intervention appears promising, defining NAFLD therapies capable of preventing fibrosis and cirrhosis requires further study...